LONDON - Chiron Corp. is spinning out the DNA vaccines technology it acquired when it took over PowderJect Pharmaceuticals plc to a team of former PowderJect managers. (BioWorld Today)
LONDON - Antisoma plc's share price was halved Monday after the company announced its lead product, R1549, failed in a Phase III ovarian cancer trial -survival of R1549-treated patients was no better than patients in the comparative arm. (BioWorld International)
LONDON - Antisoma plc's share price was halved Monday after the company announced its lead product, R1549, failed in a Phase III ovarian cancer trial -survival of R1549-treated patients was no better than patients in the comparative arm. (BioWorld International)
